Aperio Group’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$5.28M Buy
1,003,506
+6,324
+0.6% +$24.9K 0.02% 814
2020
Q3
$2.84M Sell
997,182
-19,320
-2% -$71.1K 0.01% 956
2020
Q2
$3.53M Sell
1,016,502
-345,003
-25% -$1.19M 0.01% 865
2020
Q1
$3.2M Buy
1,361,505
+1,153,279
+554% +$7.46M 0.01% 824
2019
Q4
$2.19M Buy
208,226
+79,534
+62% +$720K 0.01% 1050
2019
Q3
$1.1M Buy
128,692
+28,029
+28% +$275K ﹤0.01% 1345
2019
Q2
$1.16M Sell
100,663
-11,676
-10% -$150K ﹤0.01% 1330
2019
Q1
$1.57M Sell
112,339
-10,177
-8% -$133K 0.01% 1146
2018
Q4
$1.27M Sell
122,516
-19,533
-14% -$288K 0.01% 1178
2018
Q3
$2.43M Buy
142,049
+27,594
+24% +$474K 0.01% 961
2018
Q2
$2.06M Sell
114,455
-6,834
-6% -$137K 0.01% 1011
2018
Q1
$2.12M Sell
121,289
-14,886
-11% -$311K 0.01% 981
2017
Q4
$3.13M Buy
136,175
+13,895
+11% +$288K 0.02% 821
2017
Q3
$2.56M Buy
122,280
+23,471
+24% +$432K 0.01% 847
2017
Q2
$2M Sell
98,809
-760
-0.8% -$16.6K 0.01% 910
2017
Q1
$2.42M Buy
99,569
+5,649
+6% +$152K 0.02% 804
2016
Q4
$2.53M Sell
93,920
-775
-0.8% -$19.1K 0.02% 739
2016
Q3
$2.12M Buy
94,695
+5,697
+6% +$114K 0.02% 813
2016
Q2
$1.9M Buy
88,998
+14,920
+20% +$281K 0.01% 828
2016
Q1
$1.3M Sell
74,078
-8,516
-10% -$127K 0.01% 933
2015
Q4
$1.25M Buy
82,594
+23,339
+39% +$359K 0.01% 918
2015
Q3
$779K Buy
59,255
+1,589
+3% +$25.2K 0.01% 1084
2015
Q2
$1.08M Buy
57,666
+4,801
+9% +$99.6K 0.01% 936
2015
Q1
$993K Buy
52,865
+14,188
+37% +$243K 0.01% 943
2014
Q4
$642K Buy
38,677
+119
+0.3% +$2.51K 0.01% 1097
2014
Q3
$1.25M Buy
38,558
+919
+2% +$31.2K 0.02% 768
2014
Q2
$1.31M Buy
37,639
+1,533
+4% +$50.3K 0.02% 735
2014
Q1
$1.14M Buy
+36,106
New +$1M 0.02% 935
2013
Q4
Sell
-33,086
Closed -$792K 1015
2013
Q3
$707K Buy
33,086
+3,515
+12% +$72.2K 0.01% 989
2013
Q2
$572K Buy
+29,571
New +$645K 0.01% 977

Other funds holding PTEN

Aperio Group's PTEN Position: Q4 2020 in Review

Aperio Group increased its Patterson-UTI (PTEN) stake by 0.63% in Q4 2020, buying an estimated $24.9K and bringing the position to 1,003,506 shares worth $5.28M. The position accounts for 0.02% of the portfolio, ranked #814.

Aperio Group first reported a position in PTEN in Q2 2013 and has held it in 30 quarters since. 233 funds tracked by Wall St. Rank hold PTEN as of Q4 2020.

  • Aperio Group held 1,003,506 shares of Patterson-UTI worth $5.28M as of Q4 2020.
  • Aperio Group bought 6,324 Patterson-UTI shares in Q4 2020, an estimated $24.9K.
  • Patterson-UTI made up 0.02% of Aperio Group's portfolio in Q4 2020, its #814 holding.
  • Aperio Group first reported a position in Patterson-UTI in Q2 2013 and has held it in 30 quarters since.
  • 233 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.